Memory Pharmaceuticals and Roche Expand Development Program for MEM 3454 in Schizophrenia

News   Feb 20, 2008

 
Memory Pharmaceuticals and Roche Expand Development Program for MEM 3454 in Schizophrenia
 
 
 

RELATED ARTICLES

Mouse Study Suggests That Dietary Fat, Not Carbs, Drives Obesity

News

A mouse study that made over 100,000 measurements of body weight and fat has concluded that the sole driver of obesity in mice is increased dietary fat content.

READ MORE

Peering Inside Proteins

News

The proteins in our bodies are sophisticated structures that perform specific jobs to keep us functioning and healthy. Understanding how a protein is wired could help researchers develop ways to control its activity. A new technique lets researchers look into the atomic structures of proteins to see that wiring.

READ MORE

This ATM Dispenses Antioxidants

News

Antioxidants are molecules that counteract the damage to our bodies from harmful products of normal cells called reactive oxygen species (ROS). Now, research has found that a protein called ATM can sense the presence of ROS and responds by sounding the alarm to trigger the production of antioxidants.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy